Global Lip Cancer Clinical Trials Market Outlook: Ken Research - PowerPoint PPT Presentation

Loading...

PPT – Global Lip Cancer Clinical Trials Market Outlook: Ken Research PowerPoint presentation | free to download - id: 894cc7-MzkwM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Lip Cancer Clinical Trials Market Outlook: Ken Research

Description:

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Lip Cancer Clinical Trials Market Outlook: Ken Research


1
Global Lip Cancer Clinical Trials Market Outlook
Ken Research
2
The report titled Lip Cancer Global Clinical
Trials Review H2 2017, provides a comprehensive
analysis of lip cancer, causes, various
treatments, Mohs micrographic surgery, leading
players, basics of clinical trials and phases,
impact of lip cancer, modernization and evolution
in medical science will detect lip cancer at
early stage in the coming years.
3
  • Lip Cancer Overview Lip cancer is disruptive
    growth of cells which form injuries or tumors on
    the lips. Lip cancer is also known as the most
    common type of oral cancer. It develop in thin,
    flat cells known as squamous cells that line the
    lips, mouth, tongue, cheeks, sinuses, throat, and
    hard and soft palates. Modern lifestyle choices,
    such as smoking, drinking, sun exposure, and
    tanning, increase the risk of developing lip
    cancer. The first signs of lip cancer are noticed
    by the dentists during any routine dental
    examination. If diagnosed early lip cancers are
    highly curable. It was observed that more than
    36,000 people globally are diagnosed with oral
    cancer every year.
  • Factors, Symptoms, Available Treatments and
    Prevention of Lip Cancer Major factors that
    increase the risk for lip cancers include smoking
    or using tobacco products (cigarettes, cigars,
    pipes, or chewing tobacco), heavy use of alcohol,
    exposure to direct sunlight (both natural and
    artificial), including the use of tanning beds,
    over

4
  • long periods, infection with human papillomavirus
    (HPV), a sexually transmitted virus and above 40
    years of age as well as cases of
    immune-suppression. The symptoms of lip cancers
    are sore, lesion, blister, ulcer, or lump on the
    mouth that does not go away, a red or white patch
    on the lip, bleeding or pain on the lips and
    swelling of the jaw. The various treatments
    available for lip cancer are surgery, radiation
    therapy, chemotherapy, immunotherapy, cryotherapy
    (freezing with liquid nitrogen) and gene therapy.
    The treatment depends on the stage of the lip
    cancer and the size of the tumor. Surgery is
    performed to remove if it is a small tumor. If
    the tumor is large or at a later stage, radiation
    and chemotherapy treatments are used to shrink
    the tumor to reduce the risk of re-ocurrence. Lip
    cancer can be prevented by avoiding all types of
    tobacco, alcohol intake, and limiting exposure to
    both natural and artificial sunlight.
  • Mohs micrographic surgery is commonly used to
    treat lip cancer which involves removing thin
    layers of skin tissue, which are then

5
  • colour-coded, mapped, and microscopically
    examined. If cancer cells are detected, more
    tissue from the affected area is removed and the
    process is repeated until no more cancer can be
    found. This surgery offers the highest cure rate
    of any treatment modalities for primary or
    recurrent lip tumors. Emergency treatment is
    recommended for cases where lip cancer has spread
    and is known to interfere with the function of a
    vital organ. Men are at a greater risk than women
    in occurrence of lip cancer. Lip cancer
    diagnostic tests involve physical examination for
    sores, lumps or mouth ulcers. Biopsy, X-rays and
    CT scans are also done to determine the spread of
    lip cancer. Other diagnostic tests include
    endoscopy, exfoliative cytology, Magnetic
    Resonance Imaging (MRI), barium swallow, PET scan
    and bone scan.
  • Geography and Leading Players in Lip Cancer To
    reduce the risk of lip cancer, doctors prescribe
    regular use of photo protective lip blocks (lip
    products that contain sunscreen) because they
    help reduce exposure to U.V. radiation. Lip
    cancer market is geographically spread

6
  • across North America, Europe, Asia Pacific and
    Rest of the World. The Unites States ranks first
    in lip cancer cases, followed by Asia-Pacific
    with considerable number of lip cancer cases. The
    leading players in global lip cancer market are
    Astra Zeneca plc, Bristol Myers Squibb, Celgene,
    Eli Lilly Co., Hofmann La Roche, Pfizer, Sanofi
    Aventis, Teva Pharmaceuticals, and Novartis AG.
  • Clinical Trials for Lip Cancer Involves Four
    Phases Clinical trials are research studies that
    compare the most effective known treatment for a
    specific type or stage of cancer with a new
    approach. It can be a new drug, or combination of
    drugs or a different way of using the already
    established therapies. There are clinical trials
    for every type of cancer, to prevent cancer,
    improve early diagnosis, stop the cancer from
    coming back, reduce side effects or improve
    quality of life.
  • The first phase is where the drug is approved for
    human consumption and is tested in a small trial
    to determine the optimal safe dose which

7
  • often involves patients with different kinds of
    cancer. In second phase, the approved drug is
    tested on cases with multiple cancers to
    determine the optimal dosing and provide an early
    assessment of whether the drug works. The third
    phase involves hundreds, or even thousands of
    patients, in multiple centres with specific types
    and stages of cancer. This stage provides
    definitive evidence to support the approval of
    the drug for use in the public. The phase four is
    known as post-marketing trials where the goal is
    to make sure that no safety or other concerns
    come up after a drug is approved that may not
    have been seen in the pre-approval trials.
  • Future of Global Lip Cancer Clinical Trials It
    was observed that lip cancer clinical trials are
    collated from 80 plus different clinical trial
    registries, conferences, journals, news, etc
    across the globe. The lip cancer clinical trials
    database undergoes periodic update. Lip cancer is
    not only claiming lives but has a huge impact on
    the global economy. It also highlights the
    urgency of tackling preventable cancers globally.

8
  • With increasing modernization and evolution in
    medical science, lip cancer is expected to be
    treated at an early stage with less pain and cost
    over the coming years.
  • Key Topics Covered in the Report
  • Global Lip Cancer Clinical Trials Market Research
    Report
  • Global Lip Cancer Clinical Trials Market Size
  • Global Lip Cancer Clinical Trials Market Outlook
  • Global Lip Cancer Clinical Trials Market Forecast
  • Cancer industry clinical Trials
  • Global Lip Cancer Clinical Trials Market Analysis
  • Central Lip Cancer Therapeutics Clinical Trials
  • Europe Lip Cancer Therapeutics Clinical Trials
  • North America Lip Cancer Therapeutics Clinical
    Trials
  • Middle East Lip Cancer Therapeutics Clinical
    Trials
  • Asia Lip Cancer Therapeutics Clinical Trials

9
Lip Cancer Clinical Trials and Average Enrollment
by Top Countries South America Lip Cancer
Therapeutics Clinical Trials To know more, click
on the link below https//www.kenresearch.com/hea
lthcare/pharmaceuticals/lip-cancer-global-clinical
-trials-review-h2-2017/142643-91.html To review
related reports, click on the links
below https//www.kenresearch.com/healthcare/pharm
aceuticals/metastatic-transitional-urothelial-trac
t-cancer-global-clinical-trials-review/143043-91.h
tml https//www.kenresearch.com/healthcare/pharma
ceuticals/metastatic-prostate-cancer-global-clinic
al-trials-review/143041-91.html
10
Contact Ken Research Ankur Gupta, Head
Marketing Communications sales_at_kenresearch.com
91-124-4230204
About PowerShow.com